These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37810892)

  • 41. Global diabetic kidney disease research from 2000 to 2017: A bibliometric analysis.
    Zou LX; Sun L
    Medicine (Baltimore); 2019 Feb; 98(6):e14394. PubMed ID: 30732183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global Trends in Research of Gouty Arthritis Over Past Decade: A Bibliometric Analysis.
    Deng P; Wang S; Sun X; Qi Y; Ma Z; Pan X; Liang H; Wu J; Chen Z
    Front Immunol; 2022; 13():910400. PubMed ID: 35757713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus].
    Chernikova NA; Kamynina LL; Ametov AS; Sychev DA; Grishina EA; Ryzhikova KA
    Ter Arkh; 2020 Nov; 92(10):54-62. PubMed ID: 33346480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of average daily risk range scores for young children with type 1 diabetes mellitus using continuous glucose monitoring and self-monitoring data.
    Patton SR; Midyett LK; Dolan LM; Powers SW
    Diabetes Technol Ther; 2012 Mar; 14(3):239-43. PubMed ID: 22047051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Global trends and focuses of GLP-1RA in renal disease: a bibliometric analysis and visualization from 2005 to 2022.
    Meng Y; Wang Y; Fu W; Zhang M; Huang J; Wu H; Sun L
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3347-3361. PubMed ID: 37389601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knowledge domain and hotspots concerning photosensitive hydrogels for tissue engineering applications: A bibliometric and visualized analysis (1996-2022).
    Fu H; Yu B; Wang H; Tong H; Jiang L; Zhang Y; Meng G; Sun M; Lin J
    Front Bioeng Biotechnol; 2022; 10():1067111. PubMed ID: 36466359
    [No Abstract]   [Full Text] [Related]  

  • 50. A systematic review on clinical implication of continuous glucose monitoring in diabetes management.
    Azhar A; Gillani SW; Mohiuddin G; Majeed RA
    J Pharm Bioallied Sci; 2020; 12(2):102-111. PubMed ID: 32742108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Effectiveness of Immediate Continuous Glucose Monitoring in Hypoglycemia-Prone People with Type 1 Diabetes Compared with Hypoglycemia-Focused Psychoeducation Following a Previous Structured Education: A Randomized Controlled Trial.
    Serné EH; van den Berg IK; Racca C; van Raalte DH; Kramer MHH; de Wit M; Snoek FJ
    Diabetes Technol Ther; 2023 Jan; 25(1):50-61. PubMed ID: 36326825
    [No Abstract]   [Full Text] [Related]  

  • 52. Worldwide Bronchiolitis obliterans research: A bibliometric analysis of the published literature between 2002 and 2022.
    Cui Z; Zhou X; Luo F; Wang J; Diao J; Pan Y
    Medicine (Baltimore); 2023 Jul; 102(28):e34263. PubMed ID: 37443465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in Research Related to Premenstrual Syndrome and Premenstrual Dysphoric Disorder From 1945 to 2018: A Bibliometric Analysis.
    Gao M; Gao D; Sun H; Cheng X; An L; Qiao M
    Front Public Health; 2021; 9():596128. PubMed ID: 33968873
    [No Abstract]   [Full Text] [Related]  

  • 56. Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 Diabetes.
    Jensen MH; Cichosz SL; Hirsch IB; Vestergaard P; Hejlesen O; Seto E
    J Diabetes Sci Technol; 2021 Jul; 15(4):827-832. PubMed ID: 32456531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.
    Miller KM; Kanapka LG; Rickels MR; Ahmann AJ; Aleppo G; Ang L; Bhargava A; Bode BW; Carlson A; Chaytor NS; Gannon G; Goland R; Hirsch IB; Kiblinger L; Kruger D; Kudva YC; Levy CJ; McGill JB; O'Malley G; Peters AL; Philipson LH; Philis-Tsimikas A; Pop-Busui R; Salam M; Shah VN; Thompson MJ; Vendrame F; Verdejo A; Weinstock RS; Young L; Pratley R
    Diabetes Technol Ther; 2022 Jun; 24(6):424-434. PubMed ID: 35294272
    [No Abstract]   [Full Text] [Related]  

  • 58. Protocol for a Randomized, Crossover Trial to Decrease Time in Hypoglycemia by Combined Intervention of the Usage of Intermittent-Scanning Continuous Glucose Monitoring Device and the Structured Education Regarding its Usage: Effect of Intermittent-Scanning Continuous Glucose Monitoring to Glycemic Control Including Hypoglycemia and Quality of Life of Patients with Type 1 Diabetes Mellitus Study (ISCHIA Study).
    Suzuki S; Tone A; Murata T; Nishimura K; Miyamoto Y; Sakane N; Satoh-Asahara N; Toyoda M; Hirota Y; Matsuhisa M; Kuroda A; Kato K; Kouyama R; Miura J; Suganuma A; Tomita T; Noguchi M; Son C; Kasahara M; Ito Y; Kasama S; Hosoda K
    Tokai J Exp Clin Med; 2021 Jul; 46(2):59-68. PubMed ID: 34216477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A; Venema A; Haarsma P; Feldbrugge L; Burghard R; Rodriguez-Buritica D; Parenti G; Oosterveer MH; Derks TGJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3612-e3623. PubMed ID: 35786777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
    Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
    J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.